Reporting of endoscopy and histology of ulcerative colitis in routine clinical practice: How far we are!

Article Gastroenterology & Hepatology

Knowledge and attitudes towards the use of histological assessments in ulcerative colitis by gastroenterologists vs pathologists

Aviv Pudipeddi et al.

Summary: This study aimed to evaluate the knowledge and attitudes of gastroenterologists and pathologists towards histology guidelines and the use of histology in ulcerative colitis (UC). The survey results showed that almost all gastroenterologists and pathologists believed that histological assessment should be part of UC evaluation. However, they lacked awareness and understanding of histological scoring systems and their definitions.

WORLD JOURNAL OF GASTROENTEROLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

Real-world use of endoscopic and histological indices in ulcerative colitis: Results of a global survey

Olga Maria Nardone et al.

Summary: This study investigated the attitudes of physicians worldwide towards ulcerative colitis (UC) histology and the adoption of standardized reporting. The majority of physicians find histological activity useful in managing UC and would welcome the use of artificial intelligence systems for automated scoring. However, there is a lack of standardization in UC histology reports compared to endoscopy reports.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2023)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Endoscopy and histology in inflammatory bowel diseases patients: Complementary or alternatives?

Ferdinando D'Amico et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2022)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD

Catherine Le Berre et al.

Summary: The SPIRIT consensus group has agreed that the ultimate therapeutic goal in both CD and UC is to prevent disease impact on patients' lives, including health-related quality of life, disability, and fecal incontinence, as well as prevent complications in the short and long term, such as bowel damage, surgeries, disease extension, extraintestinal manifestations, and dysplasia or cancer. These recommendations will need to be validated in clinical studies before being implemented in disease-modification trials.

GASTROENTEROLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

Dan Turner et al.

Summary: STRIDE-II presents treatment targets for both adult and pediatric IBD, including long-term and short-term goals. These targets cover aspects such as clinical response, endoscopic healing, quality of life, and growth, providing guidance for improving patient outcomes.

GASTROENTEROLOGY (2021)

Add to Collection

Review Gastroenterology & Hepatology

AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review

Sanjay K. Murthy et al.

Summary: Improvements in disease management, endoscopic technology, and quality have significantly transformed the conceptualization and management of inflammatory bowel disease-related dysplasia over the past 20 years. A conceptual model and best practice advice have been proposed for the prevention, detection, and management of colorectal dysplasia in individuals with inflammatory bowel disease. This expert review, commissioned by the American Gastroenterological Association, aims to provide timely guidance on a topic of high clinical importance to its membership.

GASTROENTEROLOGY (2021)

Add to Collection

Review Gastroenterology & Hepatology